{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1034.582",
  "meta": {
    "versionId": "17",
    "lastUpdated": "2021-03-09T01:00:17.000-05:00"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.582",
  "version": "20210309",
  "name": "Diabetes Screening with Fasting Component (LOINC)",
  "status": "active",
  "date": "2021-03-09T01:00:17-05:00",
  "publisher": "American Academy of Neurology Steward",
  "compose": {
    "include": [
      {
        "system": "http://loinc.org",
        "version": "2.72",
        "concept": [
          {
            "code": "21004-7",
            "display": "Glucose tolerance [Interpretation] in Serum or Plasma"
          },
          {
            "code": "49688-5",
            "display": "Glucose tolerance [Interpretation] in Serum or Plasma Narrative--post 75 g glucose PO"
          },
          {
            "code": "50586-7",
            "display": "Glucose tolerance 3 hours panel - Serum or Plasma"
          },
          {
            "code": "50587-5",
            "display": "Glucose tolerance 4 hours panel - Serum or Plasma"
          },
          {
            "code": "50588-3",
            "display": "Glucose tolerance 5 hours panel - Serum or Plasma"
          },
          {
            "code": "50589-1",
            "display": "Glucose tolerance 6 hours panel - Serum or Plasma"
          },
          {
            "code": "55399-0",
            "display": "Diabetes tracking panel"
          },
          {
            "code": "72171-2",
            "display": "Glucose tolerance 2 hours panel - Serum or Plasma"
          },
          {
            "code": "93794-6",
            "display": "Glucose tolerance and insulin sensitivity 2 hour panel - Serum or Plasma"
          }
        ]
      }
    ]
  }
}